Benitec Biopharma (BNTC) Net Cash Flow (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Net Cash Flow for 7 consecutive years, with -$5.7 million as the latest value for Q2 2025.

  • Quarterly Net Cash Flow fell 115.42% to -$5.7 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $46.9 million through Jun 2025, down 3.24% year-over-year, with the annual reading at $46.9 million for FY2025, 3.24% down from the prior year.
  • Net Cash Flow hit -$5.7 million in Q2 2025 for Benitec Biopharma, down from $25.3 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $36.8 million in Q2 2024 to a low of -$6.4 million in Q1 2024.
  • Historically, Net Cash Flow has averaged $4.6 million across 5 years, with a median of -$3.4 million in 2021.
  • Biggest five-year swings in Net Cash Flow: crashed 163.37% in 2022 and later skyrocketed 997.88% in 2024.
  • Year by year, Net Cash Flow stood at -$3.3 million in 2021, then tumbled by 76.25% to -$5.9 million in 2022, then increased by 10.15% to -$5.3 million in 2023, then soared by 293.02% to $10.2 million in 2024, then crashed by 155.82% to -$5.7 million in 2025.
  • Business Quant data shows Net Cash Flow for BNTC at -$5.7 million in Q2 2025, $25.3 million in Q1 2025, and $10.2 million in Q4 2024.